London
· Delayed Price · Currency is GBP · Price in GBXMerck & Co. Statistics
Total Valuation
Merck & Co. has a market cap or net worth of GBP 203.02 billion. The enterprise value is 223.43 billion.
| Market Cap | 203.02B |
| Enterprise Value | 223.43B |
Important Dates
The next estimated earnings date is Thursday, October 31, 2024.
| Earnings Date | Oct 31, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.28% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 2.53B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.10, with an EV/FCF ratio of 21.48.
| EV / Earnings | 20.56 |
| EV / Sales | 4.64 |
| EV / EBITDA | 12.10 |
| EV / EBIT | 14.68 |
| EV / FCF | 21.48 |
Financial Position
The company has a current ratio of 1.47, with a Debt / Equity ratio of 0.87.
| Current Ratio | 1.47 |
| Quick Ratio | 0.93 |
| Debt / Equity | 0.87 |
| Debt / EBITDA | 1.58 |
| Debt / FCF | 2.87 |
| Interest Coverage | 15.94 |
Financial Efficiency
Return on equity (ROE) is 33.38% and return on invested capital (ROIC) is 15.73%.
| Return on Equity (ROE) | 33.38% |
| Return on Assets (ROA) | 11.38% |
| Return on Capital (ROIC) | 15.73% |
| Revenue Per Employee | 696,318 |
| Profits Per Employee | 153,083 |
| Employee Count | 72,000 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 2.44 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -35.56% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -35.56% |
| 50-Day Moving Average | 61.06 |
| 200-Day Moving Average | 67.86 |
| Relative Strength Index (RSI) | 27.35 |
| Average Volume (20 Days) | 12,929 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.63 |
Income Statement
In the last 12 months, Merck & Co. had revenue of GBP 49.44 billion and earned 10.87 billion in profits. Earnings per share was 4.26.
| Revenue | 49.44B |
| Gross Profit | 37.47B |
| Operating Income | 15.64B |
| Pretax Income | 12.07B |
| Net Income | 10.87B |
| EBITDA | 18.70B |
| EBIT | 15.64B |
| Earnings Per Share (EPS) | 4.26 |
Balance Sheet
The company has 8.98 billion in cash and 29.90 billion in debt, giving a net cash position of -20.92 billion.
| Cash & Cash Equivalents | 8.98B |
| Total Debt | 29.90B |
| Net Cash | -20.92B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 34.54B |
| Book Value Per Share | 13.60 |
| Working Capital | 9.61B |
Cash Flow
In the last 12 months, operating cash flow was 13.21 billion and capital expenditures -2.80 billion, giving a free cash flow of 10.40 billion.
| Operating Cash Flow | 13.21B |
| Capital Expenditures | -2.80B |
| Free Cash Flow | 10.40B |
| FCF Per Share | n/a |
Margins
Gross margin is 75.79%, with operating and profit margins of 31.64% and 21.98%.
| Gross Margin | 75.79% |
| Operating Margin | 31.64% |
| Pretax Margin | 24.41% |
| Profit Margin | 21.98% |
| EBITDA Margin | 37.82% |
| EBIT Margin | 31.64% |
| FCF Margin | 21.04% |
Dividends & Yields
Merck & Co. does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 55.64% |
| Buyback Yield | -0.28% |
| Shareholder Yield | -0.28% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Merck & Co. has an Altman Z-Score of 4.57.
| Altman Z-Score | 4.57 |
| Piotroski F-Score | n/a |